Health ❯ Obesity ❯ Weight Loss ❯ Medications

GLP-1 Drugs

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

The deal trades steep list-price cuts for expedited FDA reviews and temporary tariff relief.

U.S. Strikes Price-Cut Deals With Novo Nordisk and Eli Lilly for GLP‑1s, With Medicare Pilot in 2026

UK Regulator Probes Pancreatitis Cases Linked to GLP-1 Weight-Loss Drugs